Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||
| Net Income | -11,149 | -21,194 | -14,201 |
| Depreciation Amortization | 581 | 895 | 536 |
| Accounts receivable | 23 | 172 | 73 |
| Accounts payable and accrued liabilities | -305 | -1,006 | 1,001 |
| Other Working Capital | -3,354 | 758 | 605 |
| Other Operating Activity | 998 | 1,539 | -356 |
| Operating Cash Flow | $-13,206 | $-18,836 | $-12,342 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2 | -26 | -254 |
| Purchase Of Investment | -33,320 | N/A | N/A |
| Investing Cash Flow | $-33,322 | $-26 | $-254 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | N/A | 15,000 |
| Debt Repayment | -5,524 | -3,190 | N/A |
| Common Stock Issued | 57,253 | 8,074 | 8,517 |
| Financing Cash Flow | $51,729 | $4,884 | $23,517 |
| Exchange Rate Effect | -83 | 289 | 108 |
| Beginning Cash Position | 9,721 | 23,410 | 12,381 |
| End Cash Position | 14,839 | 9,721 | 23,410 |
| Net Cash Flow | $5,118 | $-13,689 | $11,029 |
| Free Cash Flow | |||
| Operating Cash Flow | -13,206 | -18,836 | -12,342 |
| Capital Expenditure | -3 | -26 | -265 |
| Free Cash Flow | -13,209 | -18,862 | -12,607 |